Cargando…

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

Detalles Bibliográficos
Autores principales:	Bartova, Lucie, Dold, Markus, Kautzky, Alexander, Rabl, Ulrich, Souery, Daniel, Mendlewicz, Julien, Porcelli, Stefano, Serretti, Alessandro, Zohar, Joseph, Montgomery, Stuart, Kasper, Siegfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616672/ http://dx.doi.org/10.1093/ijnp/pyw043.075

Ejemplares similares

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
por: Dold, Markus, et al.
Publicado: (2018)

Age as a moderating factor of treatment resistance in depression
por: Kautzky, Alexander, et al.
Publicado: (2023)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
por: Bartova, Lucie, et al.
Publicado: (2021)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
por: Kautzky, A., et al.
Publicado: (2018)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
por: Kraus, Christoph, et al.
Publicado: (2023)

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
por: Fabbri, Chiara, et al.
Publicado: (2018)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
por: Fabbri, Chiara, et al.
Publicado: (2020)

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
por: Zaninotto, Leonardo, et al.
Publicado: (2015)

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation
por: Fanelli, Giuseppe, et al.
Publicado: (2022)

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment
por: Dold, Markus, et al.
Publicado: (2020)

Combining machine learning algorithms for prediction of antidepressant treatment response
por: Kautzky, Alexander, et al.
Publicado: (2020)

Silexan for treatment of anxiety and depression in the context of COVID-19
por: Bartova, Lucie, et al.
Publicado: (2023)

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series
por: Bartova, L., et al.
Publicado: (2023)

Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
por: Bartova, Lucie, et al.
Publicado: (2022)

Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
por: Dold, Markus, et al.
Publicado: (2023)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders
por: Hartelius, Glenn, et al.
Publicado: (2023)

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study
por: Meyer, Bernhard M., et al.
Publicado: (2019)

The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study
por: Swoboda, Marleen M. M., et al.
Publicado: (2022)

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter
por: Milenkovic, Ivan, et al.
Publicado: (2021)

Modifications du PS pendant l' arrêt 75
por: Rosset, G, et al.
Publicado: (1975)

Towards achieving remission in the treatment of depression
por: Mendlewicz, Julien
Publicado: (2008)

KNb(1.75)V(0.25)PS(10)
por: Yu, Jaemin, et al.
Publicado: (2011)

PS226. The efficacy of light therapy in the treatment of seasonal affective disorder: A meta-analysis of randomized controlled trials
por: Friedrich, M-E., et al.
Publicado: (2016)

Neuroscience-based Nomenclature (NbN): A call for action
por: Zohar, Joseph, et al.
Publicado: (2016)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Operation du PS No. 47: Période du 7.5. au 31.5.75. (Semaines 19 à 22)
por: Dekkers, D
Publicado: (1975)

Making Sense of: Sensitization in Schizophrenia
por: Weidenauer, Ana, et al.
Publicado: (2016)

Implementing prevention of seasonal affective disorder from patients’ and physicians’ perspectives – a qualitative study
por: Nussbaumer-Streit, Barbara, et al.
Publicado: (2018)

: Wall current monitor results of the beam test in the PS on 25.6.75
por: Bossart, R, et al.
Publicado: (1975)

Reduced default mode network suppression during a working memory task in remitted major depression
por: Bartova, Lucie, et al.
Publicado: (2015)

A 75-ps Gated CMOS Image Sensor with Low Parasitic Light Sensitivity
por: Zhang, Fan, et al.
Publicado: (2016)

Psychiatric Morbidity, Utilization and Quality of Mental Health Care in Long-Term Unemployed People
por: Meiler, Birgit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3p7rn7jtdt1rms69a2ei3v4luj